Epithelial-Mesenchymal Transition, human (Scheel, 2011)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
HOXA5 | hg38_v1_chr7_-_27143672_27143719 | 0.25 | 5.5e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_-_157444044 Show fit | 1.22 |
ENST00000264192.8
|
cytohesin 1 interacting protein |
|
chr12_-_91180365 Show fit | 0.95 |
ENST00000547937.5
|
decorin |
|
chr10_-_20897288 Show fit | 0.76 |
ENST00000377122.9
|
nebulette |
|
chr3_+_12351493 Show fit | 0.57 |
ENST00000683699.1
|
peroxisome proliferator activated receptor gamma |
|
chr3_+_12351470 Show fit | 0.50 |
ENST00000287820.10
|
peroxisome proliferator activated receptor gamma |
|
chr10_+_84194527 Show fit | 0.48 |
ENST00000623527.4
|
cadherin related family member 1 |
|
chr22_-_28306645 Show fit | 0.43 |
ENST00000612946.4
|
tetratricopeptide repeat domain 28 |
|
chr2_-_160062589 Show fit | 0.42 |
ENST00000392771.1
ENST00000283243.13 |
phospholipase A2 receptor 1 |
|
chr10_+_84194621 Show fit | 0.40 |
ENST00000332904.7
|
cadherin related family member 1 |
|
chr13_+_75804169 Show fit | 0.38 |
ENST00000526371.1
ENST00000526528.1 |
LIM domain 7 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 1.1 | GO:2000230 | negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
0.1 | 1.0 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.0 | 0.9 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.0 | 0.8 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.1 | 0.5 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
0.1 | 0.4 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.0 | 0.4 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.4 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.1 | 0.3 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
0.0 | 0.2 | GO:0021564 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) vagus nerve development(GO:0021564) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.0 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.0 | 0.9 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.6 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.0 | 0.2 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.0 | 0.2 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.0 | 0.2 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.0 | 0.1 | GO:0031523 | Myb complex(GO:0031523) |
0.0 | 0.1 | GO:0005715 | late recombination nodule(GO:0005715) |
0.0 | 0.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.1 | GO:0050692 | DBD domain binding(GO:0050692) |
0.0 | 0.7 | GO:0031005 | filamin binding(GO:0031005) |
0.0 | 0.5 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.4 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.0 | 0.4 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
0.0 | 0.4 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.3 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.0 | 0.3 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.3 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.2 | GO:0004522 | ribonuclease A activity(GO:0004522) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.1 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 1.0 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.0 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.4 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |